Achema was held as scheduled from June 11 to 15, 2018 at Messe Frankfurt, Germany. Organized by the German Association for Chemical Equipment, Engineering, & Biotechnology, the show is the world's largest exhibition for chemical engineering and equipment and is renowned in the global chemical industry. Held every three years, Achema attracts more than 3,800 exhibitors and nearly 167,000 visitors from all over the world.

Following the 2017 International Pharmaceutical Industry Exhibition in the United States, CHANSE Technology strikes again, competing with GLATT, GEA, BOSHI and other world's big-name pharmaceutical equipment manufacturers ,not inferior in any respect.

CHANSE Technology has long insisted on independent research and development, and invested a lot of manpower and material resources in scientific research activities.The success of the 2017 American Exhibition has strengthened CHANSE's development strategy oriented to scientific research.

CHANSE Technology exhibited experimental intelligent fluidized bed and experimental intelligent wet granulator, which attracted domestic and foreign professionals to stop and appreciate the exchanges and discuss the topics of continuous intelligent production, industry 4.0 and other international emerging trends, and reached cooperation intentions with many international pharmaceutical companies.

In the process of attacking overseas markets, we are deeply impressed by the rapid development of international pharmaceutical technology, and CHANSE Technology has reached the world's advanced level in terms of technology and concepts after years of dedicated research and strategic partnerships with many international manufacturers.

CHANSE technology in the promotion of their own equipment at the same time, vigorously disseminate the world's advanced concepts, CHANSE will be their most advanced equipment and overall solutions to the domestic and foreign markets to synchronize the promotion of the international and domestic pharmaceutical industry to dedicate their own modest efforts to the common progress of the pharmaceutical industry.